Back to Search
Start Over
[Post-marketing surveillance systems for psychoactive prescription drug abuse].
- Source :
-
Therapie [Therapie] 2011 May-Jun; Vol. 66 (3), pp. 263-72. Date of Electronic Publication: 2011 Aug 09. - Publication Year :
- 2011
-
Abstract
- Drugs affecting the central nervous system form a unique group of products for surveillance because they could be misused, abused or diverted. Considering the characteristics of this behaviour that is often concealed, specific post-marketing surveillance systems have been developed to monitor abuse of prescription drugs in some countries. The purpose of this review is to list and to describe post-marketing surveillance systems, according their methodology, in France and in foreign countries. These programs are based on adverse effect notifications, medical or legal consequences of abuse, general or specific population-based survey, professional networks or medication databases. Some programs use simultaneously several information sources. In conclusion, the multifaceted nature, the diversity and the inventiveness of post-marketing surveillance systems reflects the complexity of the abuse issue.<br /> (© 2011 Société Française de Pharmacologie et de Thérapeutique.)
Details
- Language :
- French
- ISSN :
- 0040-5957
- Volume :
- 66
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Therapie
- Publication Type :
- Academic Journal
- Accession number :
- 21819810
- Full Text :
- https://doi.org/10.2515/therapie/2011045